McDonald, LC, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018;66(7):e1–e48.
Magill, SS, Edwards, JR, Bamberg, W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014;370:1198–1208.
Lessa, FC, Mu, Y, Bamberg, WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015;372:825–834.
Leffler, DA, Lamont, JT.
Clostridium difficile infection. N Engl J Med 2015;373(3):287–288.
Brown, KA, Daneman, N, Jones, M, et al. The drivers of acute and long-term care Clostridium difficile infection rates: a retrospective multilevel cohort study of 251 facilities. Clin Infect Dis 2017;65:1282–1288.
Slimings, C, Riley, TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother 2014;69:881–891.
Tartof, SY, Rieg, GK, Wei, R, Tseng, HF, Jacobsen, SJ, Yu, KC. A comprehensive assessment across the healthcare continuum: risk of hospital-associated Clostridium difficile infection due to outpatient and inpatient antibiotic exposure. Infect Control Hosp Epidemiol 2015;36:1409–1416.
Gross, AE, Johannes, RS, Gupta, V, Tabak, YP, Srinivasan, A, Bleasdale, SC. The effect of a piperacillin/tazobactam shortage on antimicrobial prescribing and Clostridium difficile risk in 88 US medical centers. Clin Infect Dis 2017;15:613–618.
McDonald, LC, Owings, M, Jernigan, DB.
Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003. Emerg Infect Dis 2006;12:409–415.
Bobulsky, GS, Al-Nassir, WN, Riggs, MM, Sethi, AK, Donskey, CJ.
Clostridium difficile skin contamination in patients with C. difficile–associated disease. Clin Infect Dis 2008;46:447–450.
Sethi, AK, Al-Nassir, WN, Nerandzic, MM, Bobulsky, GS, Donskey, CJ. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol 2010;31:21–27.
Brown, K, Valenta, K, Fisman, D, Simor, A, Daneman, N. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. JAMA Intern Med 2015;175:626–633.
Freedberg, DE, Salmasian, H, Cohen, B, Abrams, JA, Larson, EL. Receipt of antibiotics in hospitalized patients and risk for Clostridium difficile infection in subsequent patients who occupy the same bed. JAMA Intern Med 2016;176:1801–1808.
Kazakova, SV, Baggs, J, McDonald, LC, et al. Association between antibiotic use and hospital-onset Clostridioides difficile infection in US acute care hospitals, 2006–2012: an ecologic analysis. Clin Infect Dis 2019. doi: 10.1093/cid/ciz169.
Villafuerte-Galvez, JA, Kelly, CP. Proton pump inhibitors and risk of Clostridium difficile infection: association or causation? Curr Opin Gastroenterol 2018;34:11–18.
Cao, F, Chen, CX, Wang, M, et al. Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection. J Hosp Infect 2018;98:4–13.
Barletta, JF, Sclar, DA. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients. Crit Care 2014;18:714.
Faleck, DM, Salmasian, H, Furuya, EY, Larson, EL, Abrams, JA, Freedberg, DE. Proton pump inhibitors do not increase risk for Clostridium difficile infection in the intensive care unit. Am J Gastroenterol 2016;111:1641–1648.
Zilberberg, MD, Tabak, YP, Sievert, DM, et al. Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals. Infect Control Hosp Epidemiol 2011;32:649–655.
Tabak, YP, Zilberberg, MD, Johannes, RS, Sun, X, McDonald, LC. Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study. Infect Control Hosp Epidemiol 2013;34:588–596.
Reported uptake of CDC’s core elements of hospital antibiotic stewardship programs in US acute care hospitals, 2017. Centers for Disease Control and Prevention website. https://gis.cdc.gov/grasp/PSA/STMapView.html. Published 2017. Accessed July 26, 2019.
Yu, K, Rho, J, Morcos, M, et al. Evaluation of dedicated infectious diseases pharmacists on antimicrobial stewardship teams. Am J Health Syst Pharm 2014;71:1019–1028.
Dingle, KE, Didelot, X, Quan, TP, et al. Effects of control interventions on Clostridium difficile infection in England: an observational study. Lancet Infect Dis 2017;17:411–421.
van Santen, KL, Edwards, JR, Webb, AK, et al. The standardized antimicrobial administration ratio: a new metric for measuring and comparing antibiotic use. Clin Infect Dis 2018;67:179–185.
Kazakova, S, Baggs, J, McDonald, L, et al. Association of hospital-onset Clostridium difficile infection rates and antibiotic use in US acute care hospitals, 2006–2012: an ecologic analysis. Oral abstract session: CDI Prevention. October 5, 2017, IDWEEK, San Diego, CA. Infectious Diseases Society of America website. https://idsa.confex.com/idsa/2017/webprogram/Paper64581.html. Published 2017. Accessed March 22, 2019.
Talpaert, MJ, Gopal Rao, G, Cooper, BS, Wade, P. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother 2011;66:2168–2174.